Skip to content
ValGenesis logo — The industry standard paperless validation software for biot...

ValGenesis

The industry standard paperless validation software for biotech, pharma, medical device and other life sciences.

Founded 2005 United States Santa Clara, United States 625 employees Private Equity Total: $24.40M Medical Devices, Pharmaceutical

General Information

Company Name ValGenesis
Founded Year 2005
Location United States Santa Clara, United States
Founders / Decision Makers
Team member
Employees 625
Industries Medical Devices, Pharmaceutical
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with ValGenesis. To contact ValGenesis, visit valgenesis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ValGenesis compare?

A PDF of ValGenesis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ValGenesis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ValGenesis

ValGenesis is a leading startup in the life sciences industry, offering paperless validation software for biotech, pharma, medical device, and other related sectors. Founded in 2005 and headquartered in the United States, the company has garnered significant attention from investors, with its most recent $24.00M Private Equity Round investment on 04 May 2021 led by Morgan Stanley Expansion Capital.

Their slogan "The industry standard paperless validation software for biotech, pharma, medical device and other life sciences" signifies their commitment to revolutionizing validation and manufacturing processes in the healthcare industry. ValGenesis delivers integrated and smart solutions to support the digital transformation of life sciences, providing a portfolio that covers the entire product lifecycle.

With a focus on Medical Devices and Pharmaceutical industries, ValGenesis offers digital and technical solutions that bring substantial value to each step of the validation and manufacturing processes, as well as related activities. Their innovative approach and recent investment from Morgan Stanley Expansion Capital position them for further growth and success in the evolving life sciences sector.

Business keywords: Life Sciences, Biotech, Pharma, Medical Device, Digital Transformation, Enterprise Validation, Quality Risk Management, Process Validation, Electronic Validation, IOT Validation, Continuous Process Verification, Quality Management

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round $24.00M 1
Morgan Stanley Expansion Capital
04 May 2021
Debt Financing $400.00K 1
Lighter Capital
28 Jul 2017

ValGenesis Alternatives & Competitors

View All Alternatives
ValGenesis vs
Eupry
Eupry Denmark

Gain full control of your temperature compliance at all times. No gaps, no mess.

Series A
66 employees
Biopharma, Biotechnology
ValGenesis vs
Dot Compliance
Dot Compliance United States

Harness the power of AI for life sciences quality and compliance

Series B
188 employees
Cloud Infrastructure, Information Technology
ValGenesis vs
ZenQMS
ZenQMS United States

Life Sciences' Less Stress eQMS

Private Equity
85 employees
Computing, Enterprise Software

FAQ About ValGenesis

The industry standard paperless validation software for biotech, pharma, medical device and other life sciences.
ValGenesis was founded in 2005.
ValGenesis is headquartered in Santa Clara, United States.
ValGenesis operates in Medical Devices and Pharmaceutical. Its work centres on Life Sciences, Biotech, Pharma and Medical Device.
ValGenesis has approximately 625 employees.
ValGenesis has completed 2 funding rounds, raising a total of $24.40M. The latest funding stage is Private Equity.
Top alternatives and competitors to ValGenesis include Eupry, Dot Compliance, ZenQMS, TikaMobile, Axxam. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ValGenesis and Eupry are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ValGenesis, https://www.bouncewatch.com/company/valgenesis, updated 3 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout